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Abstract 
Background: Gestational trophoblastic neoplasia (GTN) is a curable disease that 
involves the development of malignant tumor in the woman after a normal or molar 
pregnancy. The position of surgery in GTN is not properly specified and is changing 
due to new chemotherapy protocols. However, the role of surgery is highlighted in 
chemotherapy-resistant GTN. Other indications of surgery in trophoblastic diseases 
are drug toxicity and uterine perforation. Based on the fact that most women in 
certain age tend to preserve fertility, this study reported 4 cases of successful 
treatment after fertility sparing surgery. 
Case: A hospital-based case-report study was carried out to investigate the role of 
surgery in 4 patients with GTN. In this study, acute complications, such as intra-
abdominal bleeding and liver dysfunction due to chemotherapy occurred in some 
patients. Surgery was performed and all cases underwent localized tumor removal 
while preserving the uterus. No hysterectomy surgery was performed. 
Conclusion: Surgery is supposed in specific cases of GTN, who desire preserving 
fertility. 
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Introduction 
 
estational trophoblastic neoplasia 
(GTN) most commonly follows a 
molar pregnancy (1). Myometrial 
invasion in GTN may be followed by uterine 
perforation and intraperitoneal bleeding (1). 
Uterine rupture can be potentially lethal and 
often entails hysterectomy (2). Surgery in 
GTN management has been controversial for 
years, but at present, the role of surgery in 
GTN treatment is more acceptable. In patients 
who desire preserving fertility, hysterectomy is 
usually unacceptable (3). Uterine resection of 
localized disease with uterine reconstruction 
can be an alternative, but in certain cases as 
shown in Table I, primary repair, as a 
conservative management, should be 
considered as an option (1).  
There are a few cases of uterine preservation 
after GTN diagnosis. However, in this study, 
the most indication of surgery was 
chemotherapy-resistance GTN or 
intraperitoneal hemorrhage due to uterine 
perforation. In patients with uterine rupture or 
persistent GTN with desire for pregnancy, 
physicians tend to remove the local uterine 
lesion due to invasive mole and repair the 
uterine. Most GTN cases respond to drugs 
due to new chemotherapy protocols. In rare 
cases, due to toxicity of chemotherapy drugs, 
the chemotherapy must be interrupted and the 
only treatment is surgery. 
In this study, four cases of preserving 
fertility by surgery were considered. Written 
informed consent was obtained from all 
patients prior to surgery.  
 
Case report 
 
Case 1 
A 20 year old Iranian woman, NG (nulli 
gravid) with positive pregnancy test and 
vaginal bleeding was referred to Ghaem 
Hospital. Molar pregnancy was revealed by 
sonography. In 2010/10/23, she was treated 
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by dilatation and curettage, and pathology 
showed complete hydatiform mole.  
The patient was followed up by weekly β-
hCG. Metastatic work up was done as the 
serum hCG began to rise, and it was found to 
be negative. The patient had stage 1 GTN and 
sonography revealed myometrial invasive 
mole. The patient received two courses of 
single agent therapy (methotrexate, 50 mg/m2 
weekly). Due to no response to MTX, the 
regimen was changed to Actinomycin-D (1.25 
mg/m2 weekly), followed by five courses of 
multigene chemotherapy (Etoposide, MTX, 
Actinomycin-D, Cyclophosphamide and 
Vincristine), but her serum HCG concentration 
began to rise again. Transvaginal 
ultrasonography revealed a 54 mm localized 
echogen mass with cystic formations that 
extend to the serous layer of the uterus. 
In 2011/3/9, the patient was advised to 
undergo surgery, since she was very young 
and had no child and wished to preserve her 
fertility. Thus she chose to undergo resection 
of the tumor with uterine reconstruction. An 
approximately 5×4 vesicular mass was 
removed from the fundal region of the uterus, 
thereafter, the uterus was reconstructed in 
three layers( figure 1,2 ). Her recovery from 
the surgery was uneventful. Subsequently, the 
patient received two cycles of EMA-CO( figure 
3). The serum HCG concentration rapidly 
became normal and at present, she is in 
remission. 
 
Case 2 
Here, we report a suction curettage carried 
out for a 27 year old Iranian woman 
(G3Ab2mole1) in 2012/1/2 due to partial 
hydatiform mole pregnancy. Unfortunately, 
she was lost to follow up. The patient was in 
shock (class 3) when she was hospitalized in 
our center in 2012/4/28. She was noticeably 
pale with tachycardia and low blood pressure, 
and pulses usually filiform. The patient 
immediately underwent exploratory 
laparotomy and after the evacuation of 3 L of 
hemoperitoneum and 2 L of clots and 
vesicular tissues, there was a repair in the left 
mesosalphynx with active bleeding. There 
was a 3 cm defect in the fundal area, but the 
endometrium was intact. Further, the patient 
was conservatively managed with primary 
repair of the defect and evacuation of the 
uterus. A total of 6 units of packed cells and 2 
units of FFP were transfused. After surgery, 
serum βHCG was 20580 mIU/ml. Metastatic 
work up was done completely. The chest CT 
scan revealed 3 nodular masses in the right 
and 2 nodular masses in the left lung. The 
diagnosis used was GTN stage 3 with a score 
of six (6). Intramuscularly, chemotherapy was 
ignited using MTX with a dosage of 50 mg/m2 
weekly. The patient received 9 cycles of MTX 
and showed good response to treatment with 
negative serum β-hCG level. At present, she 
is in remission. 
 
Case 3 
A 19 year old Iranian woman with 
gestational age of 18 weeks was referred to 
the gynecology oncology department. She 
had persistent spotting and ultrasound 
assessment in 2011/3/16, which revealed 
molar pregnancy. In 2011/3/19, evacuation of 
the uterus was done by dilatation and 
curettage in another city. The pathology 
showed partial hydatiform mole. After the 
surgery, the patient was not followed-up until 
2011/4/4 when her serum βhCG reached 
10545 mIU/ml.  
Thus, sonography report cited the 
probability of pregnancy residual mass and 
therefore, she was treated with D&C again 
after one month and the concentration of 
serum β HCG was found to be higher than 
36000 mIU/ml. Metastatic evaluation showed 
normal chest X-ray and brain CT scan. 
Ultrasound imaging showed a 30×35 mm 
mass in the fundus with myometrial 
involvement, which extended to the serosal 
layer of the uterus, and a nodular mass in the 
superior lobe of the left lung was seen in chest 
CT scan. The diagnosis was GTN stage 1 and 
single agent chemotherapy was ignited using 
MTX with a dose of 50 mg/m2 weekly. 
In 2011/5/10, she underwent an exploratory 
laparotomy with primary complaint of 
abdominal pain. The patient was also in shock 
due to probable uterine rupture. About 1300 
ml hemoperitoneal fluid and 300 ml clots were 
evacuated. The uterus was ruptured in the 
fundus. There was resection of molar tissue 
and repair of uterine defect with separated 
sutures similar to myomectomy repair. The 
pathology was compatible with invasive mole. 
She was treated with 11 cycles of MTX and 
two year after surgery, she had full term 
pregnancy. Cesarean section was performed 
and her body was found to be normal and 
healthy.  
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Case 4 
The fourth case was a 16 year old Iranian 
woman. About 1 year ago, after a miscarriage, 
she had continuous spotting and about 3.5 
months before being referred to our center, 
she had been treated by dilation & curettage 
for molar pregnancy in another country. Thus, 
during the procedure, the uterus was ruptured 
and reconstructed by laparotomy. The serum 
βhCG was increased during her follow up, and 
her last serum βhCG was 2945 mIU/ml prior 
to her arrival to our hospital in 2011/10/19. 
Sonography revealed an echogen mass with 
the likelihood of a trophoblastic mass. Brain 
MRI was normal, but the chest CT scan 
revealed that there were two peripheral 
nodules of 1.5 and 1.3 cm located in the right 
lung. Her disease was in stage 3, score 
8.Further, the patient was treated with 
chemotherapy and received three courses of 
EMA-CO. First, her βhCG decreased, but 
before the fourth course of chemotherapy, 
there was a rise in the serum βhCG level, as 
well as elevated liver enzymes AST: 1664 
U/L,ALT;1358 U/Land as a result, her fourth 
course of chemotherapy was postponed. 
Eventually, due to persistent elevated liver 
enzymes, she underwent surgery in 2012/3/3. 
During laparotomy, some necrotic tissues and 
a mass were seen on the posterior surface of 
the uterus (Figure 4A, 4B). The necrotic 
tissues and then the mass were resected 
completely and the uterus was reconstructed. 
In the follow up, her serum βhCG was 
reached to zero after 2 weeks and as such, 
did not receive post operation chemotherapy. 
The serum βhCG in further follow up was 
normal.  
 
Table I. Review of GTN cases with fertility sparing surgery 
Publication Case Mode of surgery Chemotherapy after surgery Etiology of surgery 
Behtash et al (5) 
18yr-G1P0 Uterus localized 
resection  
No chemotherapy Acute abdomen & shock 
19yr-G1P0 
Rojas-Espaillat et al (7) 18yr-G1 Lesion removal 2 courses of multi agent chemotherapy Chemo resistant GTN 
Estrella et al (3) 
-23yr-G1P0 Mass resection & 
Uterine repair 
MTX change to Actinomycin -D (5 cycles) Tumor rupture & hemoperitoneum 
in Ultra sonography -23yr-G1P0 MTX 0.4 mg/m
2
 for 5 days (9 cycles) 
Tjalma et al (6) 16yr-G1P0 Localized resection 3 cycles of EMACO Chemo resistant choriocarcinoma 
Case et al (8) 30yr-G5P3 Localized resection No chemotherapy Persistent choriocarcinoma 
Current issue 
-20yr-G1P0 
Localized mass 
resection 
2 cycles of EMACO Chemo resistant GTN 
-27yr-G3AB2P0 
Molar tissue 
resection 
9 cycles of MTX(50mg/m2 weekly) Shock (class 3) 
-19yr-G1P0 
Uterine defect 
primary repair  
11 cycles of MTX 
abdominal pain & shock  under 
chemotherapy 
-16yr-G1P0 Mass Resection No chemotherapy 
persistent liver toxicity by 
chemotherapy 
 
 
Figure 1. Vesicular mass in fundus of the uterus (480×360) 
 
 
Figure 2. After reconstruction of the uterus (1500×1125) 
      
Figure 3 (A, B). Pathology showed complete mole demonstrating enlarged villous with central cavitation and surrounding 
trophoblastic hyperplasia. (1500×1125) 
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Hasanzadeh et al 
606                               International Journal of Reproductive BioMedicine Vol. 14. No. 9. pp: 603-606, September 2016 
      
Figure 4 (A, B). Mass with necrotic tissues surface of the uterus (1009×1079) 
 
Discussion 
 
All the aforementioned cases were young 
individuals who desired to preserve their 
uterus and fertility. The patients were offered 
the chance to preserve fertility with close 
follow up. Fortunately, they had complete 
response after chemotherapy and surgery and 
therefore, hysterectomy was not required. In 
general, there was 100% survival of patients. 
In GTN urgent surgery due to uterine 
perforation, most physicians perform 
hysterectomy, but the results of this study and 
other case report suggested that hystorotomy 
and mass resection should be considered in 
young patients (3). The surgeon must be an 
expert in this field because during resection, 
much part of the uterus should be left for 
future fertility (4).  
Few studies have been carried out in which 
the localized uterine resection of a residual 
disease was reported, followed by uterine 
reconstruction. The patient involved young 
women who desire fertility preservation. 
Behtash et al presented two cases of young 
patients (18 and 19 years old) with acute 
abdominal pain and shock, while they were 
under chemotherapy due to persistent 
trophoblastic disease. In the emergent 
exploratory laparotomy, localized resection of 
the uterus was performed. They had their first 
successful pregnancy 5 and 4 years, 
respectively, after surgery (5). However, in this 
study, one of our cases had successful 
pregnancy after repair of the uterus. The 
myometrium may be perforated due to 
trophoblastic tumor, causing intraperitoneal 
hemorrhage. GTN with uterine rupture could 
be potentially lethal and often entails 
hysterectomy. This treatment, however, may 
be unacceptable to a woman who wishes to 
maintain her fertility (3).  
Estrella et al reported two cases of uterine 
rupture in low risk GTN, which was 
conservatively managed with repair of primary 
uterine rupture and postoperative single agent 
chemotherapy. Both patients were in their 
early reproductive years with a great desire to 
preserve future fertility (3). In this study, two of 
cases had uterine perforation and 
intraperitoneal hemorrhage. The sonographic 
characteristic in invasive mole and placental 
site trophoblastic tumor is the same and as 
such, it is mandatory to have histologic 
diagnosis before performing definitive surgery 
(Table I) (6). 
 
Conclusion 
 
Surgery should be considered in some 
cases: persistent GTN and no response to 
chemotherapy, multiple chemotherapy course, 
and severe toxicity due to chemotherapy.  
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